Open AccessTargeted Lung Cancer Drugs Benefited Real-World Patients
Author(s) -
Peter M. Goodwin
Publication year - 2018
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000550412.78313.b0
Subject(s) - anaplastic lymphoma kinase , medicine , lung cancer , clinical trial , crizotinib , oncology , cancer , adenocarcinoma , progression free survival , randomized controlled trial , hematology , overall survival , malignant pleural effusion